ProQR Therapeutics (PRQR) Equity Ratio (2021 - 2024)
Historic Equity Ratio for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to 0.53.
- ProQR Therapeutics' Equity Ratio rose 7565.16% to 0.53 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.53, marking a year-over-year increase of 7565.16%. This contributed to the annual value of 0.53 for FY2024, which is 7565.16% up from last year.
- Latest data reveals that ProQR Therapeutics reported Equity Ratio of 0.53 as of Q4 2024, which was up 7565.16% from 0.3 recorded in Q4 2023.
- ProQR Therapeutics' 5-year Equity Ratio high stood at 0.54 for Q4 2021, and its period low was 0.3 during Q4 2023.
- For the 4-year period, ProQR Therapeutics' Equity Ratio averaged around 0.44, with its median value being 0.46 (2022).
- Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 2851.49% in 2022, then skyrocketed by 7565.16% in 2024.
- Quarter analysis of 4 years shows ProQR Therapeutics' Equity Ratio stood at 0.54 in 2021, then decreased by 28.51% to 0.39 in 2022, then fell by 22.88% to 0.3 in 2023, then skyrocketed by 75.65% to 0.53 in 2024.
- Its Equity Ratio was 0.53 in Q4 2024, compared to 0.3 in Q4 2023 and 0.39 in Q4 2022.